|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/00 | (2006.01) |
| A61K 35/761 | (2015.01) | ||
| A61K 38/17 | (2006.01) | ||
| C12N 7/00 | (2006.01) | ||
| C12N 15/86 | (2006.01) | ||
| A61P 27/02 | (2006.01) |
| (11) | Number of the document | 4027983 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20780467.5 |
| Date of filing the European patent application | 2020-09-10 | |
| (97) | Date of publication of the European application | 2022-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2025-11-19 |
| (46) | Date of publication of the claims translation | 2026-02-25 |
| (86) | Number | PCT/US2020/050079 |
| Date | 2020-09-10 |
| (87) | Number | WO 2021/050649 |
| Date | 2021-03-18 |
| (30) | Number | Date | Country code |
| 201962899070 P | 2019-09-11 | US | |
| 201962913648 P | 2019-10-10 | US | |
| PCT/US2019/062066 | 2019-11-18 | WO | |
| 202062959784 P | 2020-01-10 | US | |
| 202062971835 P | 2020-02-07 | US | |
| 202063019190 P | 2020-05-01 | US | |
| 202063030819 P | 2020-05-27 | US | |
| 202063063203 P | 2020-08-07 | US |
| (72) |
GASMI, Mehdi , US
KISS, Szilard , US
OSBORNE, Aaron , US
TURPCU, Adam , US
|
| (73) |
Adverum Biotechnologies, Inc. ,
100 Cardinal Way, Redwood City, CA 94063,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Neovaskulinių akių ligų gydymas naudojant afliberceptą koduojančius AAV2 variantus |
| TREATMENT OF OCULAR NEOVASCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT |